Status:
COMPLETED
MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Prostate Cancer
Eligibility:
MALE
30+ years
Phase:
NA
Brief Summary
The purpose of this study is to target lesions of the prostate in the bone and to biopsy these lesions using MRI to identify the areas.
Detailed Description
* This study involves a one-time, MRI-guided bone marrow biopsy. Prior to this procedure, patients will need to have a bone scan performed within the last three months and a PSA blood test drawn withi...
Eligibility Criteria
Inclusion
- Histologic diagnosis of prostate cancer
- Bone scan consistent with or suspicious of metastatic prostate cancer within last three months
- Platelet count \> 50,000/ul
- PT and aPTT \< 1.5 x control
- At least one week removed from taking aspirin or coumadin
- Currently participating in protocol "Collection of Specimens and Clinical Data for Patients with Prostate Cancer or at High Risk for Prostate Cancer"
Exclusion
- Devices incompatible to MR studies (e.g. pacemakers, ear implants, etc.)
Key Trial Info
Start Date :
July 1 2001
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00165386
Start Date
July 1 2001
End Date
January 1 2006
Last Update
December 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115